About Us

We are a clinical-stage pharmaceutical company focused on Alzheimer’s

What We Do at IGC Pharma

We are advancing therapies that bring new possibilities to patients and families facing Alzheimer’s disease and related dementias. With each advancement, we move closer to a future defined by hope, dignity, and possibility.

Our Purpose

Our Purpose

Science That Listens, Technology That Cares

At IGC Pharma, our purpose is to bridge science and compassion. We harness advanced research and technology to develop therapies that not only target Alzheimer’s biology but also ease the daily struggles faced by patients and families. Every innovation is guided by empathy, dignity, and care.

Our Inspired Approach

Our Inspired Approach

Collaboration Fuels Innovation

Solving Alzheimer’s requires more than medicine — it demands unity across science, technology, and human-centered care. At IGC Pharma, our approach brings together neuroscience, data science, and clinical expertise to build comprehensive solutions. Through initiatives like the CALMA trial, we advance treatments with both rigor and compassion.

Our Mission

Our Mission

Rekindling hope, restoring lives

Inspired by the needs of patients and families, IGC Pharma relentlessly cares for a brighter future. We grow innovative and accessible treatments to transform Alzheimer’s care, empowering patients and families to create a future filled with cherished moments.

Vertically Integrated with Strategic Operations

IGC Pharma operates across strategic global locations with integrated R&D and manufacturing capabilities.

Potomac, MD
Headquarters

Vancouver, WA
Manufacturing and Processing Facility

Colombia
Clinical Research

India
Accounting & Analytics

Potomac, MD

Vancouver, WA

Colombia

India

Our Interdisciplinary Approach

We combine clinical research, advanced technology, and science to tackle Alzheimer’s from multiple directions. Our CALMA trial addresses agitation, while MINT-AD helps predict risk and cognitive decline.

Artificial Intelligence

Artificial Intelligence: Predictive models that identify risk and guide care.

Learn More →

CALMA

CALMA: Phase 2 trial advancing therapy for Alzheimer’s agitation.

Learn More →

Science
Team

Science Team :Clinical expertise driving trials with validated outcomes.

Learn More →
No thanks.